Cargando…
Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches
AIM: Description of the inflammatory bowel disease natural history in Tehran province. BACKGROUND: Inflammatory bowel disease (IBD) is a non-homogeneous disorder with an unpredictable natural history that impairs a patient's quality of life over the course of their life. As a result, providing...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817742/ https://www.ncbi.nlm.nih.gov/pubmed/35154604 |
_version_ | 1784645702993838080 |
---|---|
author | Olfatifar, Meysam Asadzadeh Aghdaei, Hamid Pourhoseingholi, Mohamad Amin Balaii, Hedieh Hashemi Nazari, Saeed Shahrokh, Shabnam Sabour, Siamak Ivanchuk, Maria Ivanchuk, Pavlo Khodakarim, Soheila Zali, Mohammad Reza Rohani, Pejman Mehralian, Gholamhossein |
author_facet | Olfatifar, Meysam Asadzadeh Aghdaei, Hamid Pourhoseingholi, Mohamad Amin Balaii, Hedieh Hashemi Nazari, Saeed Shahrokh, Shabnam Sabour, Siamak Ivanchuk, Maria Ivanchuk, Pavlo Khodakarim, Soheila Zali, Mohammad Reza Rohani, Pejman Mehralian, Gholamhossein |
author_sort | Olfatifar, Meysam |
collection | PubMed |
description | AIM: Description of the inflammatory bowel disease natural history in Tehran province. BACKGROUND: Inflammatory bowel disease (IBD) is a non-homogeneous disorder with an unpredictable natural history that impairs a patient's quality of life over the course of their life. As a result, providing evidence for efficient patient management is critical. METHODS: In this case series study, 198 IBD patients who were visited in our clinic at least three times routinely from Oct 2015 to May 2020 were included. Then, two panel-based approaches, the Multi-State Model (MSM) and random-effect ordered logistic, were used to deduce the clinical course of IBD, which included remission, mild, moderate to severe, and surgical states. RESULTS: For ulcerative colitis (UC), women had a slightly poorer condition for remission but better for moderate to severe and a faster transition from moderate to severe to mild (HR=1.490, 95% CI: 1.02-2.16) compared to men. For Crohn's disease (CD), they had a better condition for remission but a slightly poorer condition for the severe state and higher transition from mild to moderate to severe (HR=1.221, 95% CI: 0.471-3.22) than men. Oral 5-ASA had better efficacy in people with remission and/or mild states but not for those with moderate to severe states, especially in CD (mild to moderate to serve, HR=1.526, 95% CI: 0.59-3.89). Immunosuppressive drugs were better for patients with lower disease severity, especially with UC (mild to remission, HR=1.258, 95% CI: 0.75-2.09). CONCLUSION: Panel approaches have the potential efficacy to tackle the unpredictable clinical course of IBD (UC/CD). Hence, we highly recommend that our findings be included into the Iranian routine clinical environment of IBD and/or that related studies be conducted in Iran and other regions to gain a better understanding of the natural history of IBD. |
format | Online Article Text |
id | pubmed-8817742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-88177422022-02-11 Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches Olfatifar, Meysam Asadzadeh Aghdaei, Hamid Pourhoseingholi, Mohamad Amin Balaii, Hedieh Hashemi Nazari, Saeed Shahrokh, Shabnam Sabour, Siamak Ivanchuk, Maria Ivanchuk, Pavlo Khodakarim, Soheila Zali, Mohammad Reza Rohani, Pejman Mehralian, Gholamhossein Gastroenterol Hepatol Bed Bench Original Article AIM: Description of the inflammatory bowel disease natural history in Tehran province. BACKGROUND: Inflammatory bowel disease (IBD) is a non-homogeneous disorder with an unpredictable natural history that impairs a patient's quality of life over the course of their life. As a result, providing evidence for efficient patient management is critical. METHODS: In this case series study, 198 IBD patients who were visited in our clinic at least three times routinely from Oct 2015 to May 2020 were included. Then, two panel-based approaches, the Multi-State Model (MSM) and random-effect ordered logistic, were used to deduce the clinical course of IBD, which included remission, mild, moderate to severe, and surgical states. RESULTS: For ulcerative colitis (UC), women had a slightly poorer condition for remission but better for moderate to severe and a faster transition from moderate to severe to mild (HR=1.490, 95% CI: 1.02-2.16) compared to men. For Crohn's disease (CD), they had a better condition for remission but a slightly poorer condition for the severe state and higher transition from mild to moderate to severe (HR=1.221, 95% CI: 0.471-3.22) than men. Oral 5-ASA had better efficacy in people with remission and/or mild states but not for those with moderate to severe states, especially in CD (mild to moderate to serve, HR=1.526, 95% CI: 0.59-3.89). Immunosuppressive drugs were better for patients with lower disease severity, especially with UC (mild to remission, HR=1.258, 95% CI: 0.75-2.09). CONCLUSION: Panel approaches have the potential efficacy to tackle the unpredictable clinical course of IBD (UC/CD). Hence, we highly recommend that our findings be included into the Iranian routine clinical environment of IBD and/or that related studies be conducted in Iran and other regions to gain a better understanding of the natural history of IBD. Shaheed Beheshti University of Medical Sciences 2021 /pmc/articles/PMC8817742/ /pubmed/35154604 Text en ©2021 RIGLD, Research Institute for Gastroenterology and Liver Diseases https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Olfatifar, Meysam Asadzadeh Aghdaei, Hamid Pourhoseingholi, Mohamad Amin Balaii, Hedieh Hashemi Nazari, Saeed Shahrokh, Shabnam Sabour, Siamak Ivanchuk, Maria Ivanchuk, Pavlo Khodakarim, Soheila Zali, Mohammad Reza Rohani, Pejman Mehralian, Gholamhossein Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches |
title | Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches |
title_full | Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches |
title_fullStr | Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches |
title_full_unstemmed | Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches |
title_short | Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches |
title_sort | description of the inflammatory bowel disease natural history in tehran province, iran: mixed panel approaches |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817742/ https://www.ncbi.nlm.nih.gov/pubmed/35154604 |
work_keys_str_mv | AT olfatifarmeysam descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT asadzadehaghdaeihamid descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT pourhoseingholimohamadamin descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT balaiihedieh descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT hasheminazarisaeed descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT shahrokhshabnam descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT saboursiamak descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT ivanchukmaria descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT ivanchukpavlo descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT khodakarimsoheila descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT zalimohammadreza descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT rohanipejman descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches AT mehraliangholamhossein descriptionoftheinflammatoryboweldiseasenaturalhistoryintehranprovinceiranmixedpanelapproaches |